Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker BRCC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Evan Hafer Founder, Director, 10% owner | BRCC BRC Inc. | Sale | 12,000 | $11.78 | $141.3K Sale | Form 4 ↗ |
| Oct 27, 2026 | Evan Hafer Founder, Director, 10% owner | BRCC BRC Inc. | Sale | 12,000 | $11.37 | $136.5K Sale | Form 4 ↗ |
| Oct 20, 2026 | Evan Hafer Founder, Director, 10% owner | BRCC BRC Inc. | Sale | 5,572 | $10.59 | $59.0K Sale | Form 4 ↗ |
| Oct 16, 2026 | Evan Hafer Founder, Director, 10% owner | BRCC BRC Inc. | Sale | 2,724 | $10.56 | $28.8K Sale | Form 4 ↗ |
| Aug 19, 2026 | Kathryn P. Dickson Director | BRCC BRC Inc. | Buy | 50,000 | $0.85 | $42.5K Buy | Form 4 ↗ |
| Aug 17, 2026 | Stephen M. Kadenacy Director | BRCC BRC Inc. | Sale | 105,000 | $0.82 | $86.1K Sale | Form 4 ↗ |
| Aug 14, 2026 | Matthew L. Amigh Chief Financial Officer | BRCC BRC Inc. | Buy | 10,000 | $0.85 | $8,500 Buy | Form 4 ↗ |
| Jun 1, 2026 | Evan Hafer Founder, Director, 10% owner | BRCC BRC Inc. | Sale | 2.00M | $1.49 | $3.0M Sale | Form 4 ↗ |
| Mar 5, 2026 | Steven Taslitz Director | BRCC BRC Inc. | Buy | 150,000 | $0.75 | $112.5K Buy | Form 4 ↗ |
| Mar 5, 2026 | Steven Taslitz Director | BRCC BRC Inc. | Buy | 150,000 | $0.74 | $111.0K Buy | Form 4 ↗ |
| Nov 17, 2025 | Steven Taslitz Director | BRCC BRC Inc. | Buy | 100,000 | $1.29 | $129.0K Buy | Form 4 ↗ |
| Nov 12, 2025 | Steven Taslitz Director | BRCC BRC Inc. | Buy | 100,000 | $1.28 | $128.0K Buy | Form 4 ↗ |
| Aug 8, 2025 | Steven Taslitz Director | BRCC BRC Inc. | Buy | 100,000 | $1.53 | $153.0K Buy | Form 4 ↗ |
| Aug 7, 2025 | Steven Taslitz Director | BRCC BRC Inc. | Buy | 100,000 | $1.32 | $132.0K Buy | Form 4 ↗ |
| Jul 18, 2025 | Evan Hafer Director, 10% owner | BRCC BRC Inc. | Buy | 80,000 | $1.25 | $100.0K Buy | Form 4 ↗ |
| Jul 18, 2025 | Stephen M. Kadenacy Director | BRCC BRC Inc. | Buy | 80,000 | $1.25 | $100.0K Buy | Form 4 ↗ |
| Jul 18, 2025 | Kathryn P. Dickson Director | BRCC BRC Inc. | Buy | 16,000 | $1.25 | $20.0K Buy | Form 4 ↗ |
| Jul 18, 2025 | Engaged Capital Holdings, LLC 10% owner | BRCC BRC Inc. | Buy | 400,000 | $1.25 | $500.0K Buy | Form 4 ↗ |
18 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 16, 2026, 12:33 AM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances